2018PubMedOpen access

CD163+/CD68+ tumor-associated macrophages in angiosarcoma with lymphedema.

Xuemei Du, Ying Gao, Pingping Sun, Yizhi Chen, Hong Chang, Bojun Wei

Open full text 2 citations

Abstract

macrophages. VEGFR3 was expressed only in angiosarcoma tumor cells. Our study indicates a potential role of TAMs in the development of angiosarcoma with lymphedema. The VEGF signaling pathway may thus serve as a potential target for treatment of angiosarcoma.

About this research paper

What this paper is about

macrophages. VEGFR3 was expressed only in angiosarcoma tumor cells. Our study indicates a potential role of TAMs in the development of angiosarcoma with lymphedema. The VEGF signaling pathway may thus serve as a potential target for treatment of angiosarcoma.

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

macrophages. VEGFR3 was expressed only in angiosarcoma tumor cells. Our study indicates a potential role of TAMs in the development of angiosarcoma with lymphedema. The VEGF signaling pathway may thus serve as a potential target for treatment of angiosarcoma.

Key concepts: Angiosarcoma, CD68, Hemangiosarcoma, Pathology, Medicine, CD163, Immunohistochemistry, Lymphedema

Related papers

Back to paper searchBrowse research topicsOriginal source
CD163+/CD68+ tumor-associated macrophages in angiosarcoma with lymphedema. — Research Paper | ScholarLens